Swiss National Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $128M | Buy |
393,800
+29,600
| +8% | +$9.65M | 0.08% | 227 |
|
2025
Q1 | $98.3M | Buy |
364,200
+1,600
| +0.4% | +$432K | 0.07% | 248 |
|
2024
Q4 | $85.3M | Sell |
362,600
-12,800
| -3% | -$3.01M | 0.06% | 292 |
|
2024
Q3 | $103M | Buy |
375,400
+1,000
| +0.3% | +$275K | 0.07% | 264 |
|
2024
Q2 | $91M | Sell |
374,400
-1,500
| -0.4% | -$365K | 0.06% | 270 |
|
2024
Q1 | $56.2M | Sell |
375,900
-14,900
| -4% | -$2.23M | 0.04% | 390 |
|
2023
Q4 | $74.8M | Sell |
390,800
-9,800
| -2% | -$1.88M | 0.05% | 315 |
|
2023
Q3 | $70.9M | Sell |
400,600
-47,000
| -11% | -$8.32M | 0.06% | 313 |
|
2023
Q2 | $85M | Sell |
447,600
-40,700
| -8% | -$7.73M | 0.06% | 319 |
|
2023
Q1 | $97.8M | Buy |
488,300
+200
| +0% | +$40.1K | 0.07% | 292 |
|
2022
Q4 | $116M | Sell |
488,100
-35,510
| -7% | -$8.44M | 0.08% | 245 |
|
2022
Q3 | $105M | Buy |
523,610
+2,200
| +0.4% | +$440K | 0.08% | 257 |
|
2022
Q2 | $76M | Buy |
521,410
+3,400
| +0.7% | +$496K | 0.05% | 344 |
|
2022
Q1 | $84.6M | Buy |
518,010
+66,300
| +15% | +$10.8M | 0.05% | 361 |
|
2021
Q4 | $76.6M | Sell |
451,710
-12,900
| -3% | -$2.19M | 0.05% | 376 |
|
2021
Q3 | $87.7M | Sell |
464,610
-12,300
| -3% | -$2.32M | 0.06% | 329 |
|
2021
Q2 | $80.8M | Buy |
476,910
+30,086
| +7% | +$5.1M | 0.05% | 368 |
|
2021
Q1 | $63.1M | Buy |
446,824
+8,800
| +2% | +$1.24M | 0.04% | 431 |
|
2020
Q4 | $56.9M | Sell |
438,024
-8,900
| -2% | -$1.16M | 0.04% | 431 |
|
2020
Q3 | $65.1M | Buy |
446,924
+1,500
| +0.3% | +$218K | 0.05% | 346 |
|
2020
Q2 | $66M | Buy |
445,424
+12,800
| +3% | +$1.9M | 0.06% | 332 |
|
2020
Q1 | $47.1M | Buy |
432,624
+82,000
| +23% | +$8.93M | 0.05% | 358 |
|
2019
Q4 | $40.4M | Sell |
350,624
-14,800
| -4% | -$1.7M | 0.04% | 431 |
|
2019
Q3 | $29.4M | Buy |
365,424
+53,524
| +17% | +$4.3M | 0.03% | 500 |
|
2019
Q2 | $22.6M | Buy |
311,900
+9,100
| +3% | +$660K | 0.02% | 562 |
|
2019
Q1 | $28.3M | Buy |
302,800
+8,500
| +3% | +$794K | 0.03% | 508 |
|
2018
Q4 | $21.5M | Buy |
294,300
+5,400
| +2% | +$394K | 0.03% | 527 |
|
2018
Q3 | $25.3M | Sell |
288,900
-7,700
| -3% | -$674K | 0.03% | 534 |
|
2018
Q2 | $29.2M | Buy |
296,600
+13,700
| +5% | +$1.35M | 0.03% | 509 |
|
2018
Q1 | $33.7M | Sell |
282,900
-43,600
| -13% | -$5.19M | 0.04% | 447 |
|
2017
Q4 | $41.5M | Buy |
326,500
+188,600
| +137% | +$24M | 0.04% | 424 |
|
2017
Q3 | $16.2M | Hold |
137,900
| – | – | 0.02% | 604 |
|
2017
Q2 | $11M | Buy |
137,900
+10,200
| +8% | +$814K | 0.01% | 658 |
|
2017
Q1 | $6.55M | Buy |
127,700
+800
| +0.6% | +$41K | 0.01% | 833 |
|
2016
Q4 | $4.75M | Sell |
126,900
-85,900
| -40% | -$3.22M | 0.01% | 981 |
|
2016
Q3 | $14.4M | Sell |
212,800
-2,100
| -1% | -$142K | 0.02% | 577 |
|
2016
Q2 | $11.9M | Buy |
214,900
+16,700
| +8% | +$927K | 0.02% | 608 |
|
2016
Q1 | $11.9M | Buy |
198,200
+59,900
| +43% | +$3.6M | 0.02% | 594 |
|
2015
Q4 | $13M | Buy |
138,300
+3,400
| +3% | +$320K | 0.03% | 512 |
|
2015
Q3 | $10.8M | Buy |
134,900
+13,000
| +11% | +$1.04M | 0.03% | 544 |
|
2015
Q2 | $14.6M | Buy |
121,900
+39,100
| +47% | +$4.69M | 0.04% | 470 |
|
2015
Q1 | $8.65M | Buy |
82,800
+11,200
| +16% | +$1.17M | 0.02% | 590 |
|
2014
Q4 | $6.95M | Buy |
71,600
+3,700
| +5% | +$359K | 0.03% | 568 |
|
2014
Q3 | $5.3M | Buy |
67,900
+7,100
| +12% | +$555K | 0.02% | 667 |
|
2014
Q2 | $3.84M | Sell |
60,800
-2,700
| -4% | -$171K | 0.01% | 867 |
|
2014
Q1 | $4.26M | Buy |
63,500
+14,400
| +29% | +$967K | 0.02% | 791 |
|
2013
Q4 | $3.16M | Buy |
49,100
+500
| +1% | +$32.2K | 0.01% | 816 |
|
2013
Q3 | $3.11M | Sell |
48,600
-2,200
| -4% | -$141K | 0.01% | 774 |
|
2013
Q2 | $1.58M | Buy |
+50,800
| New | +$1.58M | 0.01% | 1131 |
|